Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.960
+0.030 (1.02%)
Aug 11, 2025, 1:38 PM - Market open
Paramount Global Employees
Lipocine had 16 employees as of December 31, 2024. The number of employees decreased by 1 or -5.88% compared to the previous year.
Employees
16
Change (1Y)
-1
Growth (1Y)
-5.88%
Revenue / Employee
$263,007
Profits / Employee
-$281,702
Market Cap
16.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16 | -1 | -5.88% |
| Dec 31, 2023 | 17 | 0 | - |
| Dec 31, 2022 | 17 | 4 | 30.77% |
| Dec 31, 2021 | 13 | 2 | 18.18% |
| Dec 31, 2020 | 11 | -1 | -8.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
LPCN News
- 6 days ago - Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2025 - PRNewsWire
- 6 weeks ago - Lipocine Announces First Patient Dosed in Phase 3 Clinical Trial for LPCN 1154 in Postpartum Depression - PRNewsWire
- 7 weeks ago - Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO™) as a Treatment for Postpartum Depression on July 9, 2025 - PRNewsWire
- 2 months ago - Lipocine Announces Filing of New Drug Submission for TLANDO® in Canada - PRNewsWire
- 2 months ago - Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology - PRNewsWire
- 3 months ago - Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase - PRNewsWire
- 3 months ago - Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025 - PRNewsWire
- 3 months ago - Lipocine Announces License and Supply Agreement for TLANDO® in Brazil - PRNewsWire